13 Jul Matthew Dahl
Posted at 17:23h
in
Bio
Matt Dahl joined the Manitoba Centre for Health Policy (MCHP) in 2001 as a data analyst after completing his undergraduate studies at the University of Manitoba. He has 20+ years of experience applying different programming (SAS) techniques to access and analyze large administrative databases. With a focus on pharmacoepidemiology studies, he has become an expert in the use of pharmaceutical claims data and the appropriate methods to analyze the data at MCHP.
Matt has been a member of the Manitoba CNODES site team since 2011 and joined the CNODES steering committee in 2021. He has been involved in many CNODES projects, serving in both the Manitoba site analyst and the National lead analyst roles.
CNODES Projects
Incretin based drugs and the risk of pancreatic cancer: international multicentre cohort study
Lead Analyst, CPRDVentricular tachyarrhythmia and sudden cardiac death with domperidone use in Parkinson’s Disease
Analyst, ManitobaA multicenter observational study of incretin-based drugs and heart failure
Analyst, ManitobaA multicenter observational study of incretin-based drugs and heart failure
Lead AnalystSerotonin-norepinephrine reuptake inhibitors and the risk of AKI: A cohort study of eight administrative databases and meta-analysis
Analyst, ManitobaHigher potency statins and the risk of new diabetes: multicentre, observational study of administrative databases
Analyst, ManitobaProton pump inhibitors and the risk of hospitalisation for community-acquired pneumonia: replicated cohort studies with meta-analysis
Analyst, ManitobaAssociation between incretin-based drugs and the risk of acute pancreatitis
Lead AnalystAssociation between incretin-based drugs and the risk of acute pancreatitis
Analyst, Manitoba- Analyst, Manitoba
Occurrence of pregnancy and pregnancy outcomes during isotretinoin therapy
Analyst, ManitobaAtypical antipsychotics and hyperglycemic emergencies: multicentre, retrospective cohort study of administrative data
Analyst, Manitoba- Lead Analyst
- Lead Analyst
- Analyst, Manitoba
Impact of using concomitant conventional DMARDs on adherence to biologic DMARD treatment in rheumatoid arthritis: Multi-centre, population-based cohort study
Analyst, ManitobaComparative safety of direct oral anticoagulants and warfarin in patients with venous thromboembolism: a multicenter observational study of administrative databases
Lead AnalystComparative safety of direct oral anticoagulants and warfarin in patients with venous thromboembolism: a multicenter observational study of administrative databases
Analyst, ManitobaComparative effectiveness and safety of direct oral anticoagulants versus vitamin K antagonists in nonvalvular atrial fibrillation: a Canadian multicentre observational cohort study
Analyst, ManitobaComparison of pregnancy outcomes of patients treated with ondansetron vs alternative antiemetic medications in a multinational, population-based cohort
Analyst, ManitobaUtilization and adverse outcomes of fluconazole during pregnancy
Analyst, ManitobaMajor bleeding in users of direct oral anticoagulants in atrial fibrillation: A pooled analysis of results from multiple population-based cohort studies
Analyst, ManitobaCNODES simulated data platform
CollaboratorAddressing confounding through extreme cohort restriction in large datasets: CNODES analysis of PPIs and pneumonia
CollaboratorPrescription ranitidine use and population exposure in 6 Canadian provinces, 1996 to 2019: a serial cross-sectional analysis
Analyst, ManitobaSodium glucose cotransporter 2 inhibitors and risk of major adverse cardiovascular events: multi-database retrospective cohort study
Analyst, ManitobaSodium-glucose co-transporter-2 inhibitors and the risk of urosepsis: A multi-site, prevalent new-user cohort study
Analyst, ManitobaOff-label postpartum use of domperidone in Canada: a multidatabase cohort study
Lead AnalystOff-label postpartum use of domperidone in Canada: a multidatabase cohort study
Analyst, ManitobaHydrochlorothiazide use and risk of keratinocyte carcinoma and melanoma: A multisite population-based cohort study
Lead AnalystHydrochlorothiazide use and risk of keratinocyte carcinoma and melanoma: A multisite population-based cohort study
Analyst, ManitobaSodium-glucose cotransporter 2 inhibitors and the risk of below-knee amputation: a multicenter observational study
Analyst, ManitobaSodium-glucose cotransporter-2 inhibitors and the risk for diabetic ketoacidosis: a multicenter cohort study
Analyst, ManitobaSafety of bowel cleansers when combined with bisacodyl stimulant laxative
Analyst, ManitobaUse of systemic oral fluoroquinolones in Canada
Lead AnalystUse of systemic oral fluoroquinolones in Canada
Analyst, ManitobaFluoroquinolone use for uncomplicated urinary tract infections in women: a retrospective cohort study
Lead AnalystFluoroquinolone use for uncomplicated urinary tract infections in women: a retrospective cohort study
Analyst, ManitobaFluoroquinolone use for acute bacterial sinusitis
Lead AnalystFluoroquinolone use for acute bacterial sinusitis
Analyst, ManitobaComparative effectiveness of fluoroquinolone antibiotic use in uncomplicated acute exacerbations of chronic obstructive pulmonary disease: a multi-cohort study
Lead AnalystComparative effectiveness of fluoroquinolone antibiotic use in uncomplicated acute exacerbations of chronic obstructive pulmonary disease: a multi-cohort study
Analyst, ManitobaCharacteristics of new users of newer antidiabetic drugs in Canada and the United Kingdom
Analyst, ManitobaValsartan, Losartan and Irbesartan use in the USA, UK, Canada and Denmark after the nitrosamine recalls: a descriptive cohort study
Analyst, ManitobaMethadone containing products used for opioid use disorder
Lead AnalystMethadone containing products used for opioid use disorder
Analyst, ManitobaEffectiveness and safety among direct oral anticoagulants in nonvalvular atrial fibrillation: A multi-database cohort study with meta-analysis
Analyst, Manitoba- Analyst, Manitoba
Patterns of steroid utilization in COVID-19 patients
Analyst, ManitobaRisk of Arterial and Venous Thrombotic Events Among Patients with COVID-19: A Multi-National Collaboration of Regulatory Agencies from Canada, Europe, and United States
Analyst, ManitobaValidity of diagnoses of SARS-CoV-2 infection in Canadian administrative health data: a multiprovince, population-based cohort study
Site Investigator, ManitobaValidity of diagnoses of SARS-CoV-2 infection in Canadian administrative health data: a multiprovince, population-based cohort study
Analyst, ManitobaChanges in the dispensing of opioid medications in Canada following the introduction of a tamper-deterrent formulation of long-acting oxycodone: a time series analysis
Lead Analyst, ManitobaChanges in the dispensing of opioid medications in Canada following the introduction of a tamper-deterrent formulation of long-acting oxycodone: a time series analysis
Analyst, ManitobaOutpatient Nirmatrelvir-Ritonavir and Remdesivir Utilization in Canada
Analyst, ManitobaUtilization Analysis of Tofacitinib and Other Drugs Among Individuals with Ulcerative Colitis: Feasibility Analysis
Lead AnalystUtilization Analysis of Tofacitinib and Other Drugs Among Individuals with Ulcerative Colitis: Feasibility Analysis
Analyst, ManitobaSafety of Monitoring During Use of Ozempic in People with Diabetes: A CDM Pilot Project
Analyst, ManitobaUse of Oral Fluoroquinolones in Canada: A Drug Utilization Study Update
Lead AnalystUse of Oral Fluoroquinolones in Canada: A Drug Utilization Study Update
Analyst, ManitobaAssociation Between Opioid Use and the Development of Diverticulitis
Lead AnalystAssociation Between Opioid Use and the Development of Diverticulitis
Analyst, ManitobaLong-Acting Inhalable Drugs for Chronic Obstructive Pulmonary Disease
Lead AnalystLong-Acting Inhalable Drugs for Chronic Obstructive Pulmonary Disease
Analyst, ManitobaUtilization of Antidiabetic Drugs During Pregnancy: A CDM Pilot Project
Analyst, ManitobaIntentional Self-Harm with GLP-1 Receptor Agonists for Diabetes
Analyst, Manitoba